By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Opko Health, Inc. 

Miami  Florida    U.S.A.
Phone: n/a Fax: n/a



Company News
Opko Health, Inc. Announces Third Quarter Operating And Financial Results 11/7/2014 9:48:13 AM
DSG, Inc. And Opko Health, Inc. Enter Into Enterprise Licensing Agreement For Fully Integrated EDC, IWRS, Safety, And Trial Management Solution 11/4/2014 10:38:33 AM
Neovasc Inc. (NVC), An Opko Health, Inc. Investee, Receives FDA Conditional Approval To Initiate TIARA-I Trial In U.S.: A Multinational, Multicenter Early Feasibility Trial Of The Tiaratm Transcatheter Mitral Valve 10/9/2014 11:04:18 AM
Opko Health, Inc. Supports National Prostate Cancer Council Legislation 9/29/2014 12:53:03 PM
Opko Health, Inc.'s Second Rayaldee Phase 3 Trial Meets Primary Endpoints 9/23/2014 10:57:13 AM
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Opko Health, Inc. Release: Rayaldee Phase 3 Trial Meets Primary Endpoints 8/12/2014 9:30:11 AM
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014 8:36:37 AM
Opko Health, Inc. To Announce Top Line RAYALDEE Results And Second Quarter 2014 Financial Results On August 11, 2014 8/7/2014 10:29:35 AM
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014 10:06:07 AM